We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Atlantic Global | LSE:ATL | London | Ordinary Share | GB0030419542 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 21.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
19/12/2006 15:09 | exp88 not many trades on here over the last month quite a few days no shares bought or sold and then only very low volume how much of a punt is this one ? have you got a serious holding in this company or a speculative £1000 ish type holding sorry for asking but sizing up to buy but again the volume of shares traded on it points to most holders holding under a grands worth of shares each | madasafishman | |
15/12/2006 09:41 | I'm expecting a little more buying today and in the run up to positive trading statement and new contract news in mid january...which should trigger share price rise to 19p-20p | explorer88 | |
23/11/2006 02:31 | significant buying yesterday (562,800 shares) | explorer88 | |
16/11/2006 10:51 | Part 1 of 4: Excerpts from the forthcoming PPM book - Project Portfolio Management: Leading The Corporate Vision by Shan Rajegopal, Philip McGuin and James Waller We are proud to introduce the 1st of a 4-part serialisation of the forthcoming book on Project Portfolio Management. Project Portfolio Management: Leading The Corporate Vision is a real-world business guide into the how to successfully deploy a PPM process within the business and builds a practical step-by-step framework for its successful implementation within a low-risk high value environment. The book is for executives and business leaders who need to manage projects as business investments and to measure their impact on the bottom line. It is also for programme, project, resource portfolio managers who need to improve their methods of managing multi-project environments and to ensure that they are able to make their projects accountable to the corporate goals of the business. At the centre of the book are the 10 commandments of PPM. These commandments underpin the successful implementation of a PPM process and solution and include: 1. View projects as business investments: Project Portfolio Management is not just another project management process it is about how the business manages projects as strategic short, medium and long term investments. PPM looks to empower the business, not just the project process. From the strategic viewpoint it allows stakeholders, business leaders and executives to see clearly and understand how effective their strategies are and if necessary which programmes and projects to review. From the operational view point PPM empowers the portfolio, programme, resource and project managers with tools, support and necessary corporate accountability to execute project delivery. 2. Achieve the correct balance between processes, people and tools: Implementing PPM involves a careful blend of people, processes and tools. Success is based on the balancing of all three and ensuring the correct tool selection, for example, ensuring that software is designed to support, aid and improve process effectiveness and efficiency. Remember, do not let software bend and break your business's backbone, nor allow processes to bog down and adversely affect your organisation culture. 3. Aim for low risk, high value deployment: Avoid a 'big bang' or 'rip-and-replace' approach and look to deploy PPM in bite-size chunks, by developing a Proof-of-Benefit or 'Model Office'. This approach provides an actual, real-world view of the value of a PPM solution within a low risk environment and is an excellent way to communicate its potential Return On Investment (ROI) and Return On Opportunity (ROO). 4. Ensure business-wide visibility: Enterprise- or business-wide visibility is delivered through the deployment of role based dashboards. Role based dashboards are designed to empower all project stakeholders within the business with project information that is relevant to their role and position. Role based visibility is about providing fast and effective means of integrating the strategic with the operational and delivering a practical means for real-time opportunity detection. Role based visibility enables the business to drill through layers of management and is designed to provide business and projects leaders with the ability to spot project redundancies, resource appropriately, understand budget allocation and spend, as well as keeping close tabs on project progress and how it impacts on the bottom line. 5. Establish a single version of the truth: Implement a process that accesses project information from a single data source in a real-time environment. A single point of entry keeps information consistent, accurate, complete and also ensures that the management has a single, reliable version of the truth. This single data source removes delays to management and execution of critical business processes. 6. Negotiate executive sponsorship: Sponsorship from the top provides an infrastructure whereby the right authority is empowered to drive the right behaviour in the organisations and ensures that the deployment of PPM is strategically driven. In others words, a truly strategy driven approach to managing an organisation's projects must start at the top in order for accountability and transparency to extend throughout the organisation and to lend the PPM process both credibility and suitability. 7. Implement as a change project: The implementation of Project Portfolio Management has to be managed not only as a project but as a change management project. Introducing the Project Portfolio Management process is a business process change initiative and as a result the leadership involvement and cultural change expected from the stakeholders are fundamental for the successful implementation of the portfolio process. A process champion must be actively engaged in using, funding, promoting, and defending Project Portfolio Management. Senior managers, functional managers, and project managers must understand the portfolio management objectives and processes. They must be actively involved in pushing the approved processes out to the organisation and willing to enforce the process and deliverable requirements. 8. Develop project management competence and maturity: Project managers must have the skills and tools available to them to produce quality project plans. A quality project plan indicates there is a high degree of confidence in the project manager's ability to identify the tasks necessary to meet the project objectives and to provide good estimates for the resources required to accomplish the tasks. 9. Define an agreed and accepted PPM process: The PPM process defined and established must be a consistent and repeatable process that captures project and portfolio metrics that enable consistent comparison over time across projects and the portfolio. It must be a process that obliges organisational staff to work together as a team and share resources across departments, thereby improving resource utilisation and increasing the return on investment from the portfolio of projects accomplished 10. Embed PPM capability in everyday business working: The Project Portfolio Management outputs (reports, and so on) must be used to guide decision making and enforce the process. When staffs see managers are using this data to make decisions, they will want to keep their own project elements accurate and up to date. Further, it is important to provide PPM process oversight and support to ensure staffs are properly educated to contribute to the portfolio management process. Authors: Shan Rajegopal, Philip McGuin and James Waller ISBN: 0230507166 Format: Trade Book Price: £25.00 Pub. Date: 15/03/2007 Publisher(s): Palgrave Macmillan | explorer88 | |
10/11/2006 17:42 | Expect rise to 19/20p triggered by buying and contract news in mid January | explorer88 | |
02/11/2006 15:30 | Atlantic Global Plc in partnership with Berkshire Consultancy Limted is holding a series Master Classes throughout January, February, March, April, May and June 2007. The PPM master class training courses combines classroom instruction with hands-on exercises designed to teach participants on how to deploy, execute and lead the Project Portfolio Management process. The Half Day Master Class is absolutely FREE OF CHARGE to attend. It is designed to provide participants with an introduction into how to sell and deploy a Project Portfolio Management process. You will learn What project portfolio management is and recognise the areas of pain How to prepare and organise the company to accept a project portfolio management process How to execute the project portfolio management as a change project How to embed and sustain the project portfolio management capability Successful techniques through group exercises | explorer88 | |
02/11/2006 15:07 | Explorer, the sale of £700 worth of shares at a price higher than the bid price is not always a good indicator of a coming profit warning. MJ | mjcrockett | |
02/11/2006 13:08 | Will H1 profit warning be repeated in H2? (evidence suggests probably not) | explorer88 | |
13/7/2006 11:02 | smarkmmm - atl has £1.9m cash, and a EV of only £1m | explorer88 | |
13/7/2006 10:20 | Personally, I don't trust the company. No sales growth at all - if their product was so good clients would be beating down the door. They say: "The Directors confirm that they expect the results for the year to be in line with the Company's expectations." At the AGM in April they said trading was in line with "market expectations"; there's a world of difference. Read the "Current Trading" statement in the last two annual reports. They are almost identical - the trading results were not. The directors may be trying hard, but I do not have confidence in their statement "a good second half year performance is likely." This company IMO is too small with sales of only 2m - many other larger software companies out there are rated more favourably, and have a more robust business model. | smarkmmm | |
13/7/2006 09:00 | Explorer, do you have any information which leads you to believe that the company will not return to profitability in H2 or is that just your gut feeling? and why should they re-state their accounts any more than any other software company? MJ | mjcrockett | |
13/7/2006 08:39 | MJ I don't know what Eugene expects this year. I anticipated continued losses in H1 (which have just been announced), i continue to believe that the company is being too optimistic about its prospects to return to profitability over this FY. | explorer88 | |
13/7/2006 08:29 | Explorer, I agree that a profit of £500k seems optimistic, I wonder what forecasts they are working to. MJ | mjcrockett | |
13/7/2006 08:03 | MJ That (old) forecast is from the company's own broker and is being overtaken by events. I don't believe that ATL will make a profit of £500k this year - more like breakeven. | explorer88 | |
13/7/2006 07:40 | The trading statement was not that bad. Cash up to £1.9m, some new customers and an optimistic outlook. They say that results will be in line with expectations. Sharescope shows a forecast for the full year with a profit of £0.5m and EPS of 2p. IF that is what the company is expecting to achieve then these shares are very cheap with a market cap of £3.6m at 15p. MJ | mjcrockett | |
12/7/2006 12:10 | I don't think ATL will make £0.5m profit this year. Probably next year. | explorer88 | |
11/6/2006 07:47 | Hannibal- the confientiality agreement no longer applies to me so i am going to re-post that post (feel free to moderate r33, but i think that this should be in the public eye and it in no way damages the chances of an LGB recovery; if anything it should enhance them). "Dear Langbar Action Group member It was agreed in the debate on the Bulletin Board that it would be a good idea to contact David Buchler and ask him why Edwin Coe have been excluded. I would suggest that you send the email to David at (David@dbuchler.com) and say something like the following: Dear David As an investor in Langbar, I've been told by the Action Group that the solicitor representing the shareholders, David Greene at Edwin Coe was informed by Jones Day that they are being excluded from the legal action, as the counsel/representati Was it not Edwin Coe that brought up the point that shareholders had to be represented in the legal actions against Rybak et al, otherwise the case could be struck out as not being representative? - I would like a definitive answer to that question please. I was assured that you had already agreed that Edwin Coe would be included in the legal action and had stated this fact to Nigel Smith of the Action Group. If David Greene has been excluded, then why has this fact not been communicated to Nigel? Surely he deserves a courtesy call and an explanation why? Given the small extra costs involved with keeping David Greene (and his invaluable assistance) within the case, can you please give shareholders the reasons why you no longer wish Edwin Coe to be involved? Thank you. Please send this email as soon as you can. With Best Regards Nigel Smith Adviser Langbar Action Group Tel: +44 8444 368983 Email: nigel@anomalous.biz Email is certified virus free by Symantec Norton Anti-Virus 2006 UND NUN DIE ANTWORT!!! Thank you. This is not true and whoever has given you this opinion is not giving the true story. I will make an announcement at the end of next week on wider issues. It is important shareholders stay together otherwise we will play into the hands of the former directors. With kind regards David Buchler 020 7647 9903 www.dbuchler.com Herewith my response to these irresponsible rumours. I can only imagine this has come from former directors or their supporters who are trying to divide shareholders My lawyer Sion Richards will contact David Greene of Edwin Coe next week to discuss this and the way forwards. I have already discussed future issues with Nigel Smith and received his support. Please stay firm as we have made substantial progress. I intend to hold another shareholders meeting in the next 5-6 weeks. With kind regards David Buchler 020 7647 9903 www.dbuchler.com " Post an article on this thread: Your nickname: hukka | hukka | |
19/4/2006 10:18 | Some good news. Atlantic Global Plc AGM Statement & Trading Update Atlantic Global Plc, the specialist provider of integrated business and resource management software applications, will hold its Annual General Meeting at 2.30 pm today in Cleckheaton, West Yorkshire. The following statement regarding current trading and recent progress within the Company will be made by Non-Executive Chairman, Steve Allen: "The Board can confirm that the Company has started to see results from its reorganisation and newly focussed Sales and Marketing activity. Tangible success has been demonstrated in the first quarter of 2006 by attracting new business for our software products. The purchase of Corporate Vision by Norwich Union Insurance represents a breakthrough for Atlantic Global as it is the Company's first sale into the Insurance Division, the largest discrete business area of Norwich Union. "Sales of Atlantic Global Business Solutions software products are also higher than the same point in 2005, with a significant new name sale made to AIRCOM, and orders received for additional product from existing customers including Xchanging, Computacenter, and Friends Provident. Strategic customers continue to renew their support service contracts, with many having signed for a further three-year term. "The Company's newly focussed Sales approach, combined with the successful delivery of our recent Project Portfolio Management seminars in London, give the Directors' confidence in future sales success. Current indications are that trading in the first half of 2006 is expected to show an improvement on the first half of 2005, and for the full year the company is trading in line with market expectations." - ENDS - | ianmacg | |
23/1/2006 02:51 | page. alroyrob - 20 Jan'06 - 09:59 - 5265 of 5551 Aerotus Whatever difference you type between the numbers...eg,(&from= But it will not display more than 500 posts at a time, you will need to keep adjusting the numbers if you want to see other posts, ok? mpls - 20 Jan'06 - 10:01 - 5266 of 5551 Mail! r33skyline - 23 Mar'06 - 23:32 - 12198 of 12208 click image ,right click and select properties,Highlight URL in box on left and copy ,click OK,then paste using arrow head brackets either end of this example Bracketimg src=" URL HERE "bracket Ctrl-F will brng up the find dialog. mpls - 20 Jan'06 - 10:03 - 5267 of 5551 Do this after putting this into the address bar: mpls - 20 Jan'06 - 10:04 - 5268 of 5551 etc or is there somewhere I can look these up. Thanks Cosworth1 - 14 Mar'06 - 16:45 - 7106 of 7108 tcf - trillion cubic feet bbls - billion barrels mcf - million cubic feet. bod - barrels oil day. boepd - barrels of oil equivalent per day habayyut have you had a look at CHP,AFR ? i gather u already hold PANR,UEN,VOG HABAYYUT - 19 Apr'06 - 13:53 - 6391 of 6406 talha yep also hold EME, BPRG and TAG wil look at them too, but my bankers are VOG TAG TMC and PANR to do multiples within 12 months PapalPower - 19 Apr'06 - 14:02 - 6392 of 6406 O/T Haba, keep a close eye on EKA (Eureka Mining), plenty of big events going to happen this month and next, along with December. A number of people are in both TMC and EKA I note from their posting on both threads. HABAYYUT - 19 Apr'06 - 14:02 - 6393 of 6406 thanks Papal i will | hukka | |
13/1/2006 22:17 | close to a commercial product. handycam - 13 Jan'06 - 20:40 - 2315 of 2318 For your general information:- * Higher risk because pre profitability Reason for Comment: Trading statement and announcement of new clinical trial We are starting this note with a comment on the new trials, as we consider that these could be of real significance, followed by some general and company specific comments. New Clinical Trial We divide this section into two the clinical trial itself and the possible financial implications. Clinical Trial The company stated that it had been working with a leading French doctor to develop the protocol for the first multi-centred, randomised clinical trial into the effects of haemodynamic optimisation, using the CardioQ, in patients undergoing surgery for repair of a fractured hip. This clinical trial, which has been approved by the French authorities, will be the first to treat sufficient patients to show an impact on death rates. Patient enrolment is scheduled to start in the second quarter of 2006. We understand that there will be 16 hospitals covering 400 patients in the trial. It will be the largest randomised trial undertaken to date. Fractured hips often occur in the elderly and we understand that the rate of death within one year of the incident can be over 30%. Given the consistent results from other trials, we consider that the probability is very high that the outcome will be positive. However, with such a high incidence of death in this category, we also consider that there is a high probability of a statistically significant reduction in the death rate. If that assumption were correct, then the case for adopting HDO in this type of operation would be compelling. Financial Implications We understand from the company that there are some 50,000 fractured hip operations per year in both the UK and France and that in Europe, as a whole, there may be almost 1m. That is potentially a big market. A 10% market share at £50 per probe would equate with sales of £5m, which compares with historic sales of £3m. Furthermore, we understand that the French distributor has been overstocked with probes. That reduced last year and the trial, without other sales, should reduce that to minimum holding levels thus we expect in H2 of this year, a resumption of ordering from that market. General Points In general, our experience has shown that it is very difficult to project revenues for any early stage company (our definition of early stage is pre-profitability) with any degree accuracy. It is even more difficult in the medical device field as the market is conservative and the adoption cycle long as practitioners wish to see clinical proof before committing to a new technology. However, when the breakthrough comes market penetration should be very rapid. In a company specific comment, regular readers of this service will be aware that we consider the Haemodynamic Optimisation (HDO) will become a 'Standard of Care' as a substantial number of clinical studies have shown that patients get better faster. handycam - 13 Jan'06 - 20:43 - 2316 of 2318 continues:- It saves money and anecdotal evidence suggests that it saves lives, which may change to proven see above. The largest market will be in the operating theatre as only a proportion of patients undergoing surgery visit the intensive care unit of a hospital. As far as we are aware, Deltex has the only minimal invasive HDO system that can be used in the operating theatre. We are convinced that HDO will become a standard of care and that Deltex will be a major beneficiary. Although we do not know the timing, we consider that, given the existing and projected clinical evidence and the apparent groundswell of real interest generated from the work of the 'Improving Surgical Outcomes Group' (ISOG) in the UK, the timing may be evident sooner rather than later. In the context of the ISOG, we understand that over 100 doctors attended the recent meeting in Exeter. Trading Statement The company stated that sales for the year to December 2005 will be in excess of £3.0m. That is at the low end of our projected range, but does imply a 20% increase in H2 sales year on year. The most important market for the company at present in terms of total sales and the number of clinical trials is the UK. Despite the well documented problems with the NHS, we understand that UK sales increased by around 30% despite a decline in the number of monitors sold. That demonstrates a continued increase in the number of probe sales as more patients are being treated. Revenues from probe sales should be viewed as higher quality than monitor sales as they should be recurring revenue. Conclusion We consider that HDO will become a standard of care. We are also convinced that it is when not if. We also consider that the probability of the French trial being successful is high and it could lead to major sales in France and in the rest of Europe. That is why DEMG should be considered for aggressive growth portfolios and why we have a strong buy opinion. Deltex is however still not yet profitable and the shares therefore have a high degree of risk. THIS IS POSTED FOR GENERAL INFORMATION PURPOSES ONLY AND IN THE OPEN FORUM OF THE BULLETIN BOARDS, IT IS DONE SO IN GOOD FAITH. I remain long. I hope that this has been of some help to some people. Yours etc., | hukka | |
13/1/2006 10:40 | Measurements cf cubic feet Bbl barrel being equal to 42 fluid gallons Mcf thousand cubic feet Bbls barrels MMcf million cubic feet MBbls thousand barrels Bcf billion (thousand million) of cubic feet; MMbls million barrels Tcf trillion (thousand billion) of cubic feet; Cfpd cf per day; CM cubic metres Mcfpd Mcf per day; MCM thousand cubic metres MMcfpd MMCf per day; BCM billion cubic metres How can I just let you walk away, just let you leave without a trace When I stand here taking every breath with you, ooh You're the only one who really knew me at all How can you just walk away from me, when all I can do is watch you leave Cos we've shared the laughter and the pain and even shared the tears You're the only one who really knew me at all So take a look at me now, oh there's just an empty space And there's nothing left here to remind me, just the memory of your face Ooh take a look at me now, well there's just an empty space And you coming back to me is against the odds and that's what I've got to face I wish I could just make you turn around, turn around and see me cry There's so much I need to say to you, so many reasons why You're the only one who really knew me at all So take a look at me now, well there's just an empty space And there's nothing left here to remind me, just the memory of your face Now take a look at me now, cos there's just an empty space But to wait for you, is all I can do and that's what I've got to face Take a good look at me now, cos I'll still be standing here And you coming back to me is against all odds It's the chance I've gotta take Take a look at me now | hukka | |
27/9/2005 17:51 | ATL has gone all quiet - Interims out today and no interest. Share price falls to new low. Quick glance at the accounts. Gross Profit Margin is horribly low even accounting for lower T/O. BS looks OK with lots of lovely cash (how much will be eroded before it turns cash positive again). Worryingly its debtors now stand at something like 7 months turnover - this either means a customer wont pay because its not happy with the software or has agreed delayed payment terms or it cannot pay. | adriand | |
17/9/2005 11:44 | WOW, THIS HAS TICKED UP, YIPPEE DO DA DAY!!! Skyship-->Thxs, you may well be right. We shall see :-) Wolstenhulme - 7 Mar'05 - 14:11 - 1671 of 2017 Just been reading StockHouse BB in Canada, where most of the old boys there are in the mining business and know their metal. They are expecting anywhere upto C$9 this week. The target price is C$20 by June (BFS) and an eventual C$40 to C$50 depending on the price of metals. This equates to 3 to 5p this week, 25p by June and target of 50p to GLA and thats ignoring all GLAs other projects. Sit tight, 20 mins to NDM opening bell. | jules64 | |
07/7/2005 08:53 | Post removed by ADVFN | shirishg |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions